These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10586227)

  • 1. X-linked Charcot-Marie-Tooth disease and connexin32.
    Fischbeck KH; Abel A; Lin GS; Scherer SS
    Ann N Y Acad Sci; 1999 Sep; 883():36-41. PubMed ID: 10586227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connexin32 and X-linked Charcot-Marie-Tooth disease.
    Bone LJ; Deschênes SM; Balice-Gordon RJ; Fischbeck KH; Scherer SS
    Neurobiol Dis; 1997; 4(3-4):221-30. PubMed ID: 9361298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a dominant connexin32 mutant in myelinating Schwann cells.
    Jeng LJ; Balice-Gordon RJ; Messing A; Fischbeck KH; Scherer SS
    Mol Cell Neurosci; 2006 Jul; 32(3):283-98. PubMed ID: 16790356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.
    Wang HL; Chang WT; Yeh TH; Wu T; Chen MS; Wu CY
    Neurobiol Dis; 2004 Mar; 15(2):361-70. PubMed ID: 15006706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connexins in disease.
    Bennett MV
    Nature; 1994 Mar; 368(6466):18-9. PubMed ID: 8107878
    [No Abstract]   [Full Text] [Related]  

  • 6. Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease.
    Hahn AF; Bolton CF; White CM; Brown WF; Tuuha SE; Tan CC; Ainsworth PJ
    Ann N Y Acad Sci; 1999 Sep; 883():366-82. PubMed ID: 10586261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexin32 in the peripheral nervous system. Functional analysis of mutations associated with X-linked Charcot-Marie-Tooth syndrome and implications for the pathophysiology of the disease.
    Nicholson SM; Ressot C; Gomès D; D'Andrea P; Perea J; Duval N; Bruzzone R
    Ann N Y Acad Sci; 1999 Sep; 883():168-85. PubMed ID: 10586243
    [No Abstract]   [Full Text] [Related]  

  • 8. Two novel connexin32 mutations cause early onset X-linked Charcot-Marie-Tooth disease.
    Braathen GJ; Sand JC; Bukholm G; Russell MB
    BMC Neurol; 2007 Jul; 7():19. PubMed ID: 17620124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease.
    Ressot C; Bruzzone R
    Brain Res Brain Res Rev; 2000 Apr; 32(1):192-202. PubMed ID: 10751670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered assembly of gap junction channels caused by COOH-terminal connexin32 mutants of CMTX.
    Barrio LC; Castro C; Gómez-Hernandez JM
    Ann N Y Acad Sci; 1999 Sep; 883():526-9. PubMed ID: 10586291
    [No Abstract]   [Full Text] [Related]  

  • 11. X-linked Charcot-Marie-Tooth Disease and Connexin32.
    Fischbeck KH; Abel A; Lin GS; Scherer SS
    Ann N Y Acad Sci; 1999 Oct; 883(1):36-41. PubMed ID: 29086942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot-Marie-Tooth type X: A novel mutation in the Cx32 gene with central conduction slowing.
    Seeman P; Mazanec R; Ctvrtecková M; Smilková D
    Int J Mol Med; 2001 Oct; 8(4):461-8. PubMed ID: 11562788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of targeted connexin32-deficient mice: a model for the human Charcot-Marie-Tooth (X-type) inherited disease.
    Willecke K; Temme A; Teubner B; Ott T
    Ann N Y Acad Sci; 1999 Sep; 883():302-9. PubMed ID: 10586255
    [No Abstract]   [Full Text] [Related]  

  • 14. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
    Scherer SS; Xu YT; Messing A; Willecke K; Fischbeck KH; Jeng LJ
    J Neurosci; 2005 Feb; 25(6):1550-9. PubMed ID: 15703409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked Charcot-Marie-Tooth disease: molecular analysis of interfamilial variability.
    Niewiadomski LA; Kelly TE
    Am J Med Genet; 1996 Dec; 66(2):175-8. PubMed ID: 8958325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common themes in peripheral neuropathy disease genes.
    Snipes GJ; Orfali W
    Cell Biol Int; 1998 Nov; 22(11-12):815-35. PubMed ID: 10873294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked dominant Charcot-Marie-Tooth disease and other potential gap-junction diseases of the nervous system.
    Spray DC; Dermietzel R
    Trends Neurosci; 1995 Jun; 18(6):256-62. PubMed ID: 7570999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [X-Linked Charcot-Marie-Tooth disease with a new mutation (Thr191Ala) in the connexin32].
    Kobari M; Irie J; Takizawa K; Yoshihara T; Sobue G
    Rinsho Shinkeigaku; 2000 Sep; 40(9):896-9. PubMed ID: 11257785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms of connexin32 mutations associated with CNS manifestations.
    Kleopa KA; Yum SW; Scherer SS
    J Neurosci Res; 2002 Jun; 68(5):522-34. PubMed ID: 12111842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.